Snake Antigen Ingredients TRIZ Cases
- Non-Immunogenic RNA Antigen Vaccination With PD-1 Blockade
Modified nucleosides curb innate immune activation, while PD-1/PD-L1 blockade strengthens antigen-specific responses for tumor targeting.
- Microneedle Coatings Using Biological Salts for Active Agent Release
A coatable composition with biological salts forms a dried coating on microneedles that dissolves in interstitial fluids to release active agents.
- Human TNFα Antibody Treatment for Refractory Psoriasis
Human TNFα antibodies restore efficacy in patients unresponsive to prior biologic therapies.
- 2-O-MLA Adjuvant Formulations for Urinary Tract Infection Vaccines
Modified 2-O-MLA adjuvants with specific buffers provide thermal stability and reduce reactogenicity.
- HER2-Targeted Immunoconjugate Reduces Off-Target Toxicity
An immunoconjugate delivers cytotoxic payloads directly to HER2-positive tumor cells via a targeted antibody linker system.
- Regulatory T-cell Expansion for Autoimmune Disease Treatment
A pharmaceutical composition identifies compounds that induce immune tolerance by eliciting specific responses from responder and regulatory T-cells.